Abstract

The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with antagonists or agonists of immune checkpoint inhibitors.


Claims
Owners (US)

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Sep 21, 2017
  • Application: May 8, 2015
    US US 201515310405 A
  • Priority: May 8, 2015
    US US 201515310405 A
  • Priority: May 8, 2015
    US US 2015/0029855 W
  • Priority: May 13, 2014
    US US 201461992788 P

Download Citation


Sign in to the Lens

Feedback